scholarly journals Crossed Cerebellar Diaschisis: Risk Factors and Prognostic Value in Medically Intractable Epilepsy by 18F-FDG PET/CT

2020 ◽  
Author(s):  
Yaqin Hou ◽  
Kun Guo ◽  
Xiaotong Fan ◽  
Kun Shang ◽  
Jingjuan Wang ◽  
...  

Abstract Purpose Crossed cerebellar diaschisis (CCD) has been widely studied in hemispheric stroke but is less characterized in epilepsy. In this study, we used 18F-FDG positron emission tomography (PET)/computed tomography (CT) to investigate the risk factors for CCD and its prognostic value for intractable epilepsy. Methods One hundred medically intractable epilepsy patients pathologically diagnosed with focal cortical dysplasia (FCD) postoperatively were included and classified into two groups: CCD+ and CCD-. All patients underwent 18F-FDG PET/CT preoperatively. PET/CT images were analysed qualitatively by visual assessment and semi-quantitatively using the absolute asymmetry index (|AI|). Clinical factors, including age, sex, body mass index (BMI), age at seizure onset, epilepsy duration, seizure type, epilepsy severity, electroencephalography(EEG) and brain magnetic resonance imaging (MRI), were retrospectively assessed from medical records. Follow-up outcomes were evaluated according to the Engel classification at 3, 6, 12, 24 and 36 months postoperatively.Results Of the 100 patients, 77 (77%) were classified as CCD-, and 23 (23%) were classified as CCD+. CCD+ patients had a higher number of lobes involved on PET (3.61±2.16 vs 2.26±1.01, P<0.001) and more cases of occipital hypometabolism (21.74% vs 5.19%, P=0.03) than CCD- patients. CCD- patients showed more negative MRI results than CCD+ patients (P=0.02). Patients with a poor prognosis had more cases of parietal hypometabolism on PET (P=0.02). At 12 months postoperatively, 71%(29/41) of CCD- patients and 31%(4/13) of CCD+ patients presented a favourable prognosis (P=0.02). Significant differences in the average |AI| values in the posterior frontal and anterior temporal lobes were found between CCD+ and CCD- patients (P<0.05), but no significant correlation of the |AI| between supratentorial regions and the contralateral cerebellum was identified in CCD+ patients. Conclusion The number of lobes involved on PET, structural anomalies on MRI, the lesion location on PET, the |AI| values in the posterior frontal and anterior temporal lobes may be predisposing factors for CCD. CCD occurrence may help predict the prognosis of FCD patients at 12 months postoperatively, and parietal hypometabolism on PET may indicate a poor prognosis.

2014 ◽  
Vol 33 (6) ◽  
pp. 397-398
Author(s):  
K.K. Agarwal ◽  
M. Tripathi ◽  
S. Karunanithi ◽  
C.J. Das ◽  
V. Suri ◽  
...  

2011 ◽  
Vol 26 (2) ◽  
pp. 102 ◽  
Author(s):  
BhagwantRai Mittal ◽  
Niranjan Khandelwal ◽  
KanhaiyaLal Agrawal ◽  
Anish Bhattacharya ◽  
Sudesh Prabhakar

2015 ◽  
Vol 40 (9) ◽  
pp. 757-758 ◽  
Author(s):  
Yusuf Demir ◽  
Erdem Sürücü ◽  
Vedat Çilingir ◽  
Mehmet Deniz Bulut ◽  
Temel Tombul

Author(s):  
K.K. Agarwal ◽  
M. Tripathi ◽  
S. Karunanithi ◽  
C.J. Das ◽  
V. Suri ◽  
...  

2021 ◽  
Author(s):  
Chao Li ◽  
Shuo Huang ◽  
Wenfang Tang ◽  
Fang Feng ◽  
Zhongyun Xu ◽  
...  

Abstract Objectives: This study is aimed to evaluate the risk factors for survival and prognostic value in differentiated thyroid cancer (DTC) and bone metastasis (BM) with I-131 therapy.Methods: 67 consecutive patients with DTC and BM were included between 2006 and 2019. All patients received total or near-total thyroidectomy, radioactive iodine (RAI) treatment, I-131 whole-body scan (WBS) and Fluorine-18-fluorodesoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT). Variables including patient’s gender, age, pathology, laboratory examination, characteristics of BM, treatment models, and metabolic parameters of F-18-FDG PET/CT were analyzed for disease progression and survival prognosis. Results: A total of 207 BM lesions were found in 67 patients and 28 (41.79%) patients experienced disease progression. Age stratification, thyroglobulin/thyroid-stimulating hormone (Tg/TSH) level, Tg level, PET (+) ratio and RAI (+) ratio showed significant differences between patients with progression and those without progression (p<0.05). The overall survival (OS) rate was 100% at one year, 86.56% at three years, and 43.20% at five years. Base on survival analysis, Tg/TSH level, PET (+) ratio and RAI(+) ratio were independent risk factors for PFS and OS. Of parameters of PET/CT, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were the significant prognostic factors for PFS and OS in DTC and BM patients.Conclusions: Tg/TSH level, PET (+) ratio and RAI(+) ratio are the independent risk factors for survival in patients with DTC and BM. MTV and TLG are the significant prognosis factors for PFS and OS on PET/CT imaging.


2016 ◽  
Vol 9 (2) ◽  
pp. 169-177 ◽  
Author(s):  
Laura Evangelista ◽  
Francesco Bertagna ◽  
Mattia Bertoli ◽  
Tigu Stela ◽  
Giorgio Saladini ◽  
...  

Author(s):  
Pengpeng Xu ◽  
Rui Guo ◽  
Jianhua You ◽  
Shu Cheng ◽  
Jian Li ◽  
...  

Author(s):  
Simone Krebs ◽  
Audrey Mauguen ◽  
Onur Yildirim ◽  
Vaios Hatzoglou ◽  
Jasmine H. Francis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document